Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2021-12-13 Purchase | 2021-12-15 5:21 pm | Prelude Therapeutics Inc | PRLD | Combs Andrew EVP, Head of Chemistry | 8,000 | $11.86 | $94,880 | 268,380 (Direct) | View |
| 2020-09-29 Purchase | 2020-09-29 8:11 pm | Prelude Therapeutics Inc | PRLD | Combs Andrew EVP, Head of Chemistry | 1,000 | $19 | $19,000 | 260,380 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-03-01 Option Award | 2024-03-04 6:05 pm | N/A 2034-02-28 | Prelude Therapeutics Inc | PRLD | Combs Andrew Chief Chemistry Officer | 150,000 | $0 | 150,000 (Direct) | View |
| 2023-02-07 Option Award | 2023-02-09 4:08 pm | N/A 2033-02-06 | Prelude Therapeutics Inc | PRLD | Combs Andrew EVP, Head of Chemistry | 135,000 | $0 | 135,000 (Direct) | View |
| 2022-04-01 Exercise | 2022-04-04 5:08 pm | N/A 2030-03-26 | Prelude Therapeutics Inc | PRLD | Combs Andrew EVP, Head of Chemistry | 36,062 | $0 | 354,839 (Direct) | View |
| 2022-03-31 Exercise | 2022-04-04 5:08 pm | N/A N/A | Prelude Therapeutics Inc | PRLD | Combs Andrew EVP, Head of Chemistry | 36,062 | $1.89 | 354,839 (Direct) | View |
| 2022-02-15 Option Award | 2022-02-17 7:07 pm | N/A 2032-02-14 | Prelude Therapeutics Inc | PRLD | Combs Andrew EVP, Head of Chemistry | 100,000 | $0 | 100,000 (Direct) | View |
| 2021-07-20 Option Award | 2021-07-22 6:07 pm | N/A 2031-07-19 | Prelude Therapeutics Inc | PRLD | Combs Andrew EVP, Head of Chemistry | 95,000 | $0 | 95,000 (Direct) | View |
Ownership | 2020-09-24 7:07 pm | N/A N/A | Prelude Therapeutics Inc | PRLD | Combs Andrew EVP, Head of Chemistry | 0 | $0 | 462,560 (Direct) | View |